ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers

May 31, 2002

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010

U.S. Cancer Mortality Dropped Slightly In 2003, ACS Report Finds.

February 10, 2006

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

September 10, 1993

In Brief: Schweiler Resigns, President Appoints Former Massachusetts Congresswoman Margaret Heckler

January 21, 1983